<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33127758</PMID><DateCompleted><Year>2021</Year><Month>01</Month><Day>25</Day></DateCompleted><DateRevised><Year>2021</Year><Month>04</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1091-6490</ISSN><JournalIssue CitedMedium="Internet"><Volume>117</Volume><Issue>46</Issue><PubDate><Year>2020</Year><Month>Nov</Month><Day>17</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>Loss of TDP-43 in astrocytes leads to motor deficits by triggering A1-like reactive phenotype and triglial dysfunction.</ArticleTitle><Pagination><StartPage>29101</StartPage><EndPage>29112</EndPage><MedlinePgn>29101-29112</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1073/pnas.2007806117</ELocationID><Abstract><AbstractText>Patients with amyotrophic lateral sclerosis (ALS) can have abnormal TDP-43 aggregates in the nucleus and cytosol of their surviving neurons and glia. Although accumulating evidence indicates that astroglial dysfunction contributes to motor neuron degeneration in ALS, the normal function of TDP-43 in astrocytes are largely unknown, and the role of astroglial TDP-43 loss to ALS pathobiology remains to be clarified. Herein, we show that TDP-43-deleted astrocytes exhibit a cell-autonomous increase in GFAP immunoreactivity without affecting astrocyte or microglia proliferation. At the transcriptomic level, TDP-43-deleted astrocytes resemble A1-reactive astrocytes and induce microglia to increase C1q expression. These astrocytic changes do not cause loss of motor neurons in the spinal cord or denervation at the neuromuscular junction. In contrast, there is a selective reduction of mature oligodendrocytes, but not oligodendrocyte precursor cells, suggesting triglial dysfunction mediated by TDP-43 loss in astrocytes. Moreover, mice with astroglial TDP-43 deletion develop motor, but not sensory, deficits. Taken together, our results demonstrate that TDP-43 is required to maintain the protective functions of astrocytes relevant to the development of motor deficits in mice.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Audrey Yi Tyan</ForeName><Initials>AYT</Initials><Identifier Source="ORCID">0000-0001-9668-8222</Identifier><AffiliationInfo><Affiliation>Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, 117549 Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agrawal</LastName><ForeName>Ira</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0002-2195-6090</Identifier><AffiliationInfo><Affiliation>Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, 117549 Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ho</LastName><ForeName>Wan Yun</ForeName><Initials>WY</Initials><AffiliationInfo><Affiliation>Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, 117549 Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yen</LastName><ForeName>Yi-Chun</ForeName><Initials>YC</Initials><AffiliationInfo><Affiliation>Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, 117549 Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pinter</LastName><ForeName>Ashley J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, 117549 Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jerry</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-6393-9029</Identifier><AffiliationInfo><Affiliation>Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, 117549 Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Phua</LastName><ForeName>Qi Xuan Cheryl</ForeName><Initials>QXC</Initials><Identifier Source="ORCID">0000-0001-5416-0200</Identifier><AffiliationInfo><Affiliation>Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, 117549 Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koh</LastName><ForeName>Katrianne Bethia</ForeName><Initials>KB</Initials><Identifier Source="ORCID">0000-0002-4614-0688</Identifier><AffiliationInfo><Affiliation>Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, 117549 Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Jer-Cherng</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, 117549 Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanford</LastName><ForeName>Emma</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-3780-3320</Identifier><AffiliationInfo><Affiliation>Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, 117549 Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Man</LastName><ForeName>Jodie Hon Kiu</ForeName><Initials>JHK</Initials><Identifier Source="ORCID">0000-0002-2155-469X</Identifier><AffiliationInfo><Affiliation>Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, 117549 Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Peiyan</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-3734-2461</Identifier><AffiliationInfo><Affiliation>Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, 117600 Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Program in Neuroscience and Behavior Disorders, Duke-NUS Medical School, 169857 Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gutmann</LastName><ForeName>David H</ForeName><Initials>DH</Initials><Identifier Source="ORCID">0000-0002-3127-5045</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Washington University School of Medicine in St. Louis, St. Louis, MO 63110.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tucker-Kellogg</LastName><ForeName>Greg</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-8407-9251</Identifier><AffiliationInfo><Affiliation>Computational Biology Programme, Faculty of Science, National University of Singapore, 117558 Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biological Sciences, Faculty of Science, National University of Singapore, 117558 Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ling</LastName><ForeName>Shuo-Chien</ForeName><Initials>SC</Initials><Identifier Source="ORCID">0000-0002-0300-8812</Identifier><AffiliationInfo><Affiliation>Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, 117549 Singapore, Singapore; shuochien@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Program in Neuroscience and Behavior Disorders, Duke-NUS Medical School, 169857 Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Healthy Longevity, National University Health System, 117549 Singapore, Singapore.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>10</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C578077">TDP-43 protein, mouse</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001253" MajorTopicYN="N">Astrocytes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D049109" MajorTopicYN="N">Cell Proliferation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017353" MajorTopicYN="N">Gene Deletion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017628" MajorTopicYN="N">Microglia</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009469" MajorTopicYN="N">Neuromuscular Junction</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009836" MajorTopicYN="N">Oligodendroglia</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="Y">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059467" MajorTopicYN="N">Transcriptome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">A1-reactive astrocytes</Keyword><Keyword MajorTopicYN="N">TDP-43</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis (ALS)</Keyword><Keyword MajorTopicYN="N">cell-autonomous</Keyword><Keyword MajorTopicYN="N">triglial dysfunction</Keyword></KeywordList><CoiStatement>The authors declare no competing interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>11</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>1</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>10</Month><Day>31</Day><Hour>5</Hour><Minute>30</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33127758</ArticleId><ArticleId IdType="pmc">PMC7682406</ArticleId><ArticleId IdType="doi">10.1073/pnas.2007806117</ArticleId><ArticleId IdType="pii">2007806117</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sreedharan J., et al. , TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319, 1668&#x2013;1672 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7116650</ArticleId><ArticleId IdType="pubmed">18309045</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabashi E., et al. , TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat. Genet. 40, 572&#x2013;574 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18372902</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Deerlin V. M., et al. , TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: A genetic and histopathological analysis. Lancet Neurol. 7, 409&#x2013;416 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3546119</ArticleId><ArticleId IdType="pubmed">18396105</ArticleId></ArticleIdList></Reference><Reference><Citation>Lattante S., Rouleau G. A., Kabashi E., TARDBP and FUS mutations associated with amyotrophic lateral sclerosis: Summary and update. Hum. Mutat. 34, 812&#x2013;826 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23559573</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., et al. , Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314, 130&#x2013;133 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai T., et al. , TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 351, 602&#x2013;611 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">17084815</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling S.-C., Polymenidou M., Cleveland D. W., Converging mechanisms in ALS and FTD: Disrupted RNA and protein homeostasis. Neuron 79, 416&#x2013;438 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4411085</ArticleId><ArticleId IdType="pubmed">23931993</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie I. R., Rademakers R., Neumann M., TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia. Lancet Neurol. 9, 995&#x2013;1007 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20864052</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohan Z., Matej R., Rusina R., Kovacs G. G., Oligodendroglial response in the spinal cord in TDP-43 proteinopathy with motor neuron involvement. Neurodegener. Dis. 14, 117&#x2013;124 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">25115814</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan R. H., Ke Y. D., Ittner L. M., Halliday G. M., ALS/FTLD: Experimental models and reality. Acta Neuropathol. 133, 177&#x2013;196 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28058507</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee E. B., Lee V. M.-Y., Trojanowski J. Q., Gains or losses: Molecular mechanisms of TDP43-mediated neurodegeneration. Nat. Rev. Neurosci. 13, 38&#x2013;50 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3285250</ArticleId><ArticleId IdType="pubmed">22127299</ArticleId></ArticleIdList></Reference><Reference><Citation>Ou S. H., Wu F., Harrich D., Garc&#xed;a-Mart&#xed;nez L. F., Gaynor R. B., Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs. J. Virol. 69, 3584&#x2013;3596 (1995).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC189073</ArticleId><ArticleId IdType="pubmed">7745706</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier-Tourenne C., Polymenidou M., Cleveland D. W., TDP-43 and FUS/TLS: Emerging roles in RNA processing and neurodegeneration. Hum. Mol. Genet. 19, R46&#x2013;R64 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3167692</ArticleId><ArticleId IdType="pubmed">20400460</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling S.-C., Synaptic paths to neurodegeneration: The emerging role of TDP-43 and FUS in synaptic functions. Neural Plast. 2018, 8413496 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5925147</ArticleId><ArticleId IdType="pubmed">29755516</ArticleId></ArticleIdList></Reference><Reference><Citation>Ederle H., Dormann D., TDP-43 and FUS en route from the nucleus to the cytoplasm. FEBS Lett. 591, 1489&#x2013;1507 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28380257</ArticleId></ArticleIdList></Reference><Reference><Citation>Alami N. H., et al. , Axonal transport of TDP-43 mRNA granules is impaired by ALS-causing mutations. Neuron 81, 536&#x2013;543 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3939050</ArticleId><ArticleId IdType="pubmed">24507191</ArticleId></ArticleIdList></Reference><Reference><Citation>Majumder P., Chu J.-F., Chatterjee B., Swamy K. B. S., Shen C. J., Co-regulation of mRNA translation by TDP-43 and Fragile X syndrome protein FMRP. Acta Neuropathol. 132, 721&#x2013;738 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5073124</ArticleId><ArticleId IdType="pubmed">27518042</ArticleId></ArticleIdList></Reference><Reference><Citation>Neelagandan N., et al. , TDP-43 enhances translation of specific mRNAs linked to neurodegenerative disease. Nucleic Acids Res. 314, 130&#x2013;21 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6326785</ArticleId><ArticleId IdType="pubmed">30357366</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W., et al. , The inhibition of TDP-43 mitochondrial localization blocks its neuronal toxicity. Nat. Med. 22, 869&#x2013;878 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4974139</ArticleId><ArticleId IdType="pubmed">27348499</ArticleId></ArticleIdList></Reference><Reference><Citation>Bose J. K., Huang C.-C., Shen C.-K. J., Regulation of autophagy by neuropathological protein TDP-43. J. Biol. Chem. 286, 44441&#x2013;44448 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3247982</ArticleId><ArticleId IdType="pubmed">22052911</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia Q., et al. , TDP-43 loss of function increases TFEB activity and blocks autophagosome-lysosome fusion. EMBO J. 35, 121&#x2013;142 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4718457</ArticleId><ArticleId IdType="pubmed">26702100</ArticleId></ArticleIdList></Reference><Reference><Citation>Roczniak-Ferguson A., Ferguson S. M., Pleiotropic requirements for human TDP-43 in the regulation of cell and organelle homeostasis. Life Sci. Alliance 2, e201900358 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6749094</ArticleId><ArticleId IdType="pubmed">31527135</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., et al. , An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J. Neurosci. 34, 11929&#x2013;11947 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4152602</ArticleId><ArticleId IdType="pubmed">25186741</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen N. J., Barres B. A., Neuroscience: Glia&#x2014;More than just brain glue. Nature 457, 675&#x2013;677 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">19194443</ArticleId></ArticleIdList></Reference><Reference><Citation>Liddelow S. A., Barres B. A., Reactive astrocytes: Production, function, and therapeutic potential. Immunity 46, 957&#x2013;967 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28636962</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams K. L., Gallo V., The diversity and disparity of the glial scar. Nat. Neurosci. 21, 9&#x2013;15 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5937232</ArticleId><ArticleId IdType="pubmed">29269757</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson M. A., et al. , Astrocyte scar formation aids central nervous system axon regeneration. Nature 532, 195&#x2013;200 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5243141</ArticleId><ArticleId IdType="pubmed">27027288</ArticleId></ArticleIdList></Reference><Reference><Citation>Liddelow S. A., et al. , Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541, 481&#x2013;487 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5404890</ArticleId><ArticleId IdType="pubmed">28099414</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y. et al. .; Alzheimer&#x2019;s Disease Neuroimaging Initiative , ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy. Nature 549, 523&#x2013;527 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5641217</ArticleId><ArticleId IdType="pubmed">28959956</ArticleId></ArticleIdList></Reference><Reference><Citation>Yun S. P., et al. , Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson&#x2019;s disease. Nat. Med. 24, 931&#x2013;938 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6039259</ArticleId><ArticleId IdType="pubmed">29892066</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibson E. M., et al. , Methotrexate chemotherapy induces persistent tri-glial dysregulation that underlies chemotherapy-related cognitive impairment. Cell 176, 43&#x2013;55.e13 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6329664</ArticleId><ArticleId IdType="pubmed">30528430</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilieva H., Polymenidou M., Cleveland D. W., Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J. Cell Biol. 187, 761&#x2013;772 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2806318</ArticleId><ArticleId IdType="pubmed">19951898</ArticleId></ArticleIdList></Reference><Reference><Citation>Haidet-Phillips A. M., et al. , Astrocytes from familial and sporadic ALS patients are toxic to motor neurons. Nat. Biotechnol. 29, 824&#x2013;828 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3170425</ArticleId><ArticleId IdType="pubmed">21832997</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer K., et al. , Direct conversion of patient fibroblasts demonstrates non-cell autonomous toxicity of astrocytes to motor neurons in familial and sporadic ALS. Proc. Natl. Acad. Sci. U.S.A. 111, 829&#x2013;832 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3896192</ArticleId><ArticleId IdType="pubmed">24379375</ArticleId></ArticleIdList></Reference><Reference><Citation>Qian K., et al. , Sporadic ALS astrocytes induce neuronal degeneration in vivo. Stem Cell Reports 8, 843&#x2013;855 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5390239</ArticleId><ArticleId IdType="pubmed">28366455</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong J., et al. , Expression of ALS-linked TDP-43 mutant in astrocytes causes non-cell-autonomous motor neuron death in rats. EMBO J. 32, 1917&#x2013;1926 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3981181</ArticleId><ArticleId IdType="pubmed">23714777</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas F., Cortes N., Abarzua S., Dyrda A., van Zundert B., Astrocytes expressing mutant SOD1 and TDP43 trigger motoneuron death that is mediated via sodium channels and nitroxidative stress. Front. Cell. Neurosci. 8, 24 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3916762</ArticleId><ArticleId IdType="pubmed">24570655</ArticleId></ArticleIdList></Reference><Reference><Citation>Serio A., et al. , Astrocyte pathology and the absence of non-cell autonomy in an induced pluripotent stem cell model of TDP-43 proteinopathy. Proc. Natl. Acad. Sci. U.S.A. 110, 4697&#x2013;4702 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3607024</ArticleId><ArticleId IdType="pubmed">23401527</ArticleId></ArticleIdList></Reference><Reference><Citation>Haidet-Phillips A. M., et al. , Altered astrocytic expression of TDP-43 does not influence motor neuron survival. Exp. Neurol. 250, 250&#x2013;259 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">24120466</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang S. H., et al. , Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosis. Nat. Neurosci. 16, 571&#x2013;579 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3637847</ArticleId><ArticleId IdType="pubmed">23542689</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., et al. , Cell-autonomous requirement of TDP-43, an ALS/FTD signature protein, for oligodendrocyte survival and myelination. Proc. Natl. Acad. Sci. U.S.A. 115, E10941&#x2013;E10950 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6243235</ArticleId><ArticleId IdType="pubmed">30373824</ArticleId></ArticleIdList></Reference><Reference><Citation>Paolicelli R. C., et al. , TDP-43 depletion in microglia promotes amyloid clearance but also induces synapse loss. Neuron 95, 297&#x2013;308.e6 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5519492</ArticleId><ArticleId IdType="pubmed">28669544</ArticleId></ArticleIdList></Reference><Reference><Citation>Bajenaru M. L., et al. , Astrocyte-specific inactivation of the neurofibromatosis 1 gene (NF1) is insufficient for astrocytoma formation. Mol. Cell. Biol. 22, 5100&#x2013;5113 (2002).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC139771</ArticleId><ArticleId IdType="pubmed">12077339</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoller J. Z., et al. , Cre reporter mouse expressing a nuclear localized fusion of GFP and &#x3b2;-galactosidase reveals new derivatives of Pax3-expressing precursors. Genesis 46, 200&#x2013;204 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2747029</ArticleId><ArticleId IdType="pubmed">18395835</ArticleId></ArticleIdList></Reference><Reference><Citation>Polymenidou M., et al. , Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat. Neurosci. 14, 459&#x2013;468 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3094729</ArticleId><ArticleId IdType="pubmed">21358643</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayala Y. M., et al. , TDP-43 regulates its mRNA levels through a negative feedback loop. EMBO J. 30, 277&#x2013;288 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3025456</ArticleId><ArticleId IdType="pubmed">21131904</ArticleId></ArticleIdList></Reference><Reference><Citation>Zamanian J. L., et al. , Genomic analysis of reactive astrogliosis. J. Neurosci. 32, 6391&#x2013;6410 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3480225</ArticleId><ArticleId IdType="pubmed">22553043</ArticleId></ArticleIdList></Reference><Reference><Citation>Brites D., Vaz A. R., Microglia centered pathogenesis in ALS: Insights in cell interconnectivity. Front. Cell. Neurosci. 8, 117 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4033073</ArticleId><ArticleId IdType="pubmed">24904276</ArticleId></ArticleIdList></Reference><Reference><Citation>Chhor V., et al. , Characterization of phenotype markers and neuronotoxic potential of polarised primary microglia in vitro. Brain Behav. Immun. 32, 70&#x2013;85 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3694309</ArticleId><ArticleId IdType="pubmed">23454862</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao W., Beers D. R., Appel S. H., Immune-mediated mechanisms in the pathoprogression of amyotrophic lateral sclerosis. NeuroImmune Pharmacol. 8, 888&#x2013;899 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4126425</ArticleId><ArticleId IdType="pubmed">23881705</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans M. C., Couch Y., Sibson N., Turner M. R., Inflammation and neurovascular changes in amyotrophic lateral sclerosis. Mol. Cell. Neurosci. 53, 34&#x2013;41 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23110760</ArticleId></ArticleIdList></Reference><Reference><Citation>Sofroniew M. V., Vinters H. V., Astrocytes: Biology and pathology. Acta Neuropathologica 119, 7&#x2013;35 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2799634</ArticleId><ArticleId IdType="pubmed">20012068</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsoucas D., et al. , Accurate estimation of cell-type composition from gene expression data. Nat. Commun. 10, 2975 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6611906</ArticleId><ArticleId IdType="pubmed">31278265</ArticleId></ArticleIdList></Reference><Reference><Citation>Han X., et al. , Mapping the Mouse Cell Atlas by microwell-seq. Cell 172, 1091&#x2013;1107.e17 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29474909</ArticleId></ArticleIdList></Reference><Reference><Citation>Traka M., et al. , A genetic mouse model of adult-onset, pervasive central nervous system demyelination with robust remyelination. Brain 133, 3017&#x2013;3029 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4415057</ArticleId><ArticleId IdType="pubmed">20851998</ArticleId></ArticleIdList></Reference><Reference><Citation>Stolt C. C., et al. , Terminal differentiation of myelin-forming oligodendrocytes depends on the transcription factor Sox10. Genes Dev. 16, 165&#x2013;170 (2002).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC155320</ArticleId><ArticleId IdType="pubmed">11799060</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang C., et al. , Partial loss of TDP-43 function causes phenotypes of amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. U.S.A. 111, E1121&#x2013;E1129 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3970502</ArticleId><ArticleId IdType="pubmed">24616503</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L., et al. , GFAP mutations in astrocytes impair oligodendrocyte progenitor proliferation and myelination in an hiPSC model of Alexander disease. Cell Stem Cell 23, 239&#x2013;251.e6 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6230521</ArticleId><ArticleId IdType="pubmed">30075130</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker A. K., et al. , Astrocytic TDP-43 pathology in Alexander disease. J. Neurosci. 34, 6448&#x2013;6458 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4012304</ArticleId><ArticleId IdType="pubmed">24806671</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai J., et al. , A crucial role for Olig2 in white matter astrocyte development. Development 134, 1887&#x2013;1899 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17428828</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo L., et al. , Optimizing nervous system-specific gene targeting with Cre driver lines: Prevalence of germline recombination and influencing factors. Neuron 106, 37&#x2013;65.e5 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7377387</ArticleId><ArticleId IdType="pubmed">32027825</ArticleId></ArticleIdList></Reference><Reference><Citation>Uchino A., et al. , Incidence and extent of TDP-43 accumulation in aging human brain. Acta Neuropathol. Commun. 3, 35 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4473839</ArticleId><ArticleId IdType="pubmed">26091809</ArticleId></ArticleIdList></Reference><Reference><Citation>Nag S., et al. , TDP-43 pathology and memory impairment in elders without pathologic diagnoses of AD or FTLD. Neurology 88, 653&#x2013;660 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5317379</ArticleId><ArticleId IdType="pubmed">28087828</ArticleId></ArticleIdList></Reference><Reference><Citation>Josephs K. A., et al. , TDP-43 is a key player in the clinical features associated with Alzheimer&#x2019;s disease. Acta Neuropathol. 127, 811&#x2013;824 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4172544</ArticleId><ArticleId IdType="pubmed">24659241</ArticleId></ArticleIdList></Reference><Reference><Citation>Josephs K. A., et al. , Staging TDP-43 pathology in Alzheimer&#x2019;s disease. Acta Neuropathol. 127, 441&#x2013;450 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3944799</ArticleId><ArticleId IdType="pubmed">24240737</ArticleId></ArticleIdList></Reference><Reference><Citation>Siuda J., Fujioka S., Wszolek Z. K., Parkinsonian syndrome in familial frontotemporal dementia. Parkinsonism Relat. Disord. 20, 957&#x2013;964 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4160731</ArticleId><ArticleId IdType="pubmed">24998994</ArticleId></ArticleIdList></Reference><Reference><Citation>Aoki N., et al. , Hippocampal sclerosis in Lewy body disease is a TDP-43 proteinopathy similar to FTLD-TDP Type A. Acta Neuropathol. 129, 53&#x2013;64 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4282950</ArticleId><ArticleId IdType="pubmed">25367383</ArticleId></ArticleIdList></Reference><Reference><Citation>Nag S., et al. , Hippocampal sclerosis and TDP-43 pathology in aging and Alzheimer disease. Ann. Neurol. 77, 942&#x2013;952 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4447563</ArticleId><ArticleId IdType="pubmed">25707479</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson P. T., et al. , Limbic-predominant age-related TDP-43 encephalopathy (LATE): Consensus working group report. Brain 142, 1503&#x2013;1527 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6536849</ArticleId><ArticleId IdType="pubmed">31039256</ArticleId></ArticleIdList></Reference><Reference><Citation>R Core Team , R: A Language and Environment for Statistical Computing (R Foundation for Statistical Computing, 2019).</Citation></Reference><Reference><Citation>Bates D., M&#xe4;chler M., Bolker B., Walker S., Fitting linear mixed-effects models using lme4. J. Stat. Softw. 67, 1&#x2013;48 (2015).</Citation></Reference><Reference><Citation>Mazerolle M. J., AICcmodavg: Model Selection and Multimodel Inference Based on (Q)AIC(c), https://CRAN.R-project.org/package=AICcmodavg (2019). Accessed 4 April 2020.</Citation></Reference><Reference><Citation>Lenth R., Singmann H., Love J., Buerkner P., Herve M., emmeans: Estimated Marginal Means, aka Least-Squares Means, https://CRAN.R-project.org/package=emmeans (2020). Accessed 4 April 2020.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>